AU2001254567A1 - Polypeptides for use as a vaccine and/or treatment for hiv infection - Google Patents
Polypeptides for use as a vaccine and/or treatment for hiv infectionInfo
- Publication number
- AU2001254567A1 AU2001254567A1 AU2001254567A AU5456701A AU2001254567A1 AU 2001254567 A1 AU2001254567 A1 AU 2001254567A1 AU 2001254567 A AU2001254567 A AU 2001254567A AU 5456701 A AU5456701 A AU 5456701A AU 2001254567 A1 AU2001254567 A1 AU 2001254567A1
- Authority
- AU
- Australia
- Prior art keywords
- vaccine
- polypeptides
- treatment
- hiv infection
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20127700P | 2000-05-02 | 2000-05-02 | |
US60/201,277 | 2000-05-02 | ||
PCT/CA2001/000586 WO2001083535A2 (en) | 2000-05-02 | 2001-05-01 | Polypeptides for use as a vaccine and/or treatment for hiv infection |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001254567A1 true AU2001254567A1 (en) | 2001-11-12 |
Family
ID=22745202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001254567A Abandoned AU2001254567A1 (en) | 2000-05-02 | 2001-05-01 | Polypeptides for use as a vaccine and/or treatment for hiv infection |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001254567A1 (en) |
WO (1) | WO2001083535A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3718720B2 (en) * | 2003-05-23 | 2005-11-24 | 国立大学法人 北海道大学 | New bioactive peptides isolated from insects |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991004273A2 (en) * | 1989-09-22 | 1991-04-04 | Idec Pharmaceuticals Corp. | Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
CA2082948C (en) * | 1990-05-16 | 2000-07-11 | Joseph G. Sodroski | Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
US5750332A (en) * | 1994-01-19 | 1998-05-12 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Peptomers with enhanced immunogenicity |
ZA975889B (en) * | 1996-07-08 | 1998-02-23 | Genentech Inc | HIV envelope polypeptides and vaccine. |
-
2001
- 2001-05-01 WO PCT/CA2001/000586 patent/WO2001083535A2/en active Application Filing
- 2001-05-01 AU AU2001254567A patent/AU2001254567A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001083535A3 (en) | 2002-10-03 |
WO2001083535A2 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002220027A1 (en) | Medical grasping device | |
AU2001241423A1 (en) | Needleless syringe | |
CZ20011229A3 (en) | Ophthalmological preparations | |
AU2002336760A1 (en) | Mutable vaccines | |
IL150961A0 (en) | Human immunodeficiency virus vaccine | |
AU6086300A (en) | Recombinant envelope vaccine against flavivirus infection | |
AU1167602A (en) | Methods of therapy for hiv infection | |
EP1421185A4 (en) | Rapid cryobaric sterilization and vaccine preparation | |
AU2001265253A1 (en) | Treatment of hiv using hyperthermia | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
AU5306300A (en) | Surgical finger protector and implement | |
AU2002213882A1 (en) | Attenuated hiv strains and use thereof | |
AU2001254561A1 (en) | Immunizing against hiv infection | |
AU2002239395A1 (en) | Hiv treatment with benzimidazoles | |
AU2002213420A1 (en) | Single-use syringe | |
AU2001260236A1 (en) | Restricted use syringe | |
AU6904101A (en) | Infection model | |
AU2001254567A1 (en) | Polypeptides for use as a vaccine and/or treatment for hiv infection | |
EP1490396A4 (en) | Immunogenic hiv peptides for use as reagents and vaccines | |
AU2002221760A1 (en) | Vaccine for treating allergy | |
AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
AU4957800A (en) | Vaccine against isa virus | |
AU2002213755A1 (en) | A vaccine for acids and its preparation and use | |
AU2001288795A1 (en) | Eia vaccine and diagnostic | |
AU2002351176A1 (en) | Peptides and use thereof in therapeutic agents against hiv infection |